Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo de Braud

Showing results (31-40 of 497) with videos related to

Pageof 50
Sort By:
Critical Reviews in Oncology/Hematology|October 21, 2015
Combination or single-agent chemotherapy as adjuvant treatment of gastric cancer: A systematic review and meta-analysis of published trialsRoberto Iacovelli, Filippo Pietrantonio, Claudia Maggi, et al.
Tumori|December 2, 2017
Bilateral parotid gland metastases from gastric signet-ring cell carcinomaFederico Nichetti, Federica Morano, Alessandra Fabbri, et al.
Tumori|September 10, 2015
Trastuzumab cardiac toxicity: a problem we put our heart intoGiacomo Bregni, Giulia Galli, Arpine Gevorgyan, et al.
Personalized Medicine|May 17, 2018
Predictive testing for DPD deficiency in a patient with familial history of fluoropyrimidine-associated toxicityFelicia Stefania Falvella, Stefania Cheli, Filippo de Braud, et al.
Breast Cancer Research and Treatment|November 3, 2016
Platinum salts in advanced breast cancer: a systematic review and meta-analysis of randomized clinical trialsFausto Petrelli, Sandro Barni, Giacomo Bregni, et al.
JCO Precision Oncology|February 1, 2022
Circulating Tumor DNA Analysis in Colorectal Cancer: From Dream to RealityCarlotta Antoniotti, Filippo Pietrantonio, Salvatore Corallo, et al.
Tumori|February 18, 2015
Rationale and protocol of SOAP: a phase II study to evaluate the efficacy of sorafenib as second-line treatment after pazopanib in patients with advanced renal cell carcinomaRoberto Iacovelli, Elena Verzoni, Paolo Grassi, et al.
Future Oncology (London, England)|October 11, 2013
Palonosetron plus dexamethasone in highly emetogenic chemotherapy: pooled data from two Phase III trialsLuigi Celio, Francesco Agustoni, Francesca Ricchini, et al.
Tumori|December 10, 2020
Prolonged benefit from palbociclib plus letrozole in heavily pretreated advanced male breast cancer: case reportEmma Zattarin, Francesca Ligorio, Federico Nichetti, et al.
American Journal of Clinical Oncology|July 2, 2019
Artificial Intelligence Estimates the Importance of Baseline Factors in Predicting Response to Anti-PD1 in Metastatic MelanomaAlice Indini, Lorenza Di Guardo, Carolina Cimminiello, et al.
Pageof 50

Showing results (31-40 of 497) with videos related to

Sort By:
Pageof 50
Critical Reviews in Oncology/Hematology|October 21, 2015
Combination or single-agent chemotherapy as adjuvant treatment of gastric cancer: A systematic review and meta-analysis of published trialsRoberto Iacovelli, Filippo Pietrantonio, Claudia Maggi, et al.
Tumori|December 2, 2017
Bilateral parotid gland metastases from gastric signet-ring cell carcinomaFederico Nichetti, Federica Morano, Alessandra Fabbri, et al.
Tumori|September 10, 2015
Trastuzumab cardiac toxicity: a problem we put our heart intoGiacomo Bregni, Giulia Galli, Arpine Gevorgyan, et al.
Personalized Medicine|May 17, 2018
Predictive testing for DPD deficiency in a patient with familial history of fluoropyrimidine-associated toxicityFelicia Stefania Falvella, Stefania Cheli, Filippo de Braud, et al.
Breast Cancer Research and Treatment|November 3, 2016
Platinum salts in advanced breast cancer: a systematic review and meta-analysis of randomized clinical trialsFausto Petrelli, Sandro Barni, Giacomo Bregni, et al.
JCO Precision Oncology|February 1, 2022
Circulating Tumor DNA Analysis in Colorectal Cancer: From Dream to RealityCarlotta Antoniotti, Filippo Pietrantonio, Salvatore Corallo, et al.
Tumori|February 18, 2015
Rationale and protocol of SOAP: a phase II study to evaluate the efficacy of sorafenib as second-line treatment after pazopanib in patients with advanced renal cell carcinomaRoberto Iacovelli, Elena Verzoni, Paolo Grassi, et al.
Future Oncology (London, England)|October 11, 2013
Palonosetron plus dexamethasone in highly emetogenic chemotherapy: pooled data from two Phase III trialsLuigi Celio, Francesco Agustoni, Francesca Ricchini, et al.
Tumori|December 10, 2020
Prolonged benefit from palbociclib plus letrozole in heavily pretreated advanced male breast cancer: case reportEmma Zattarin, Francesca Ligorio, Federico Nichetti, et al.
American Journal of Clinical Oncology|July 2, 2019
Artificial Intelligence Estimates the Importance of Baseline Factors in Predicting Response to Anti-PD1 in Metastatic MelanomaAlice Indini, Lorenza Di Guardo, Carolina Cimminiello, et al.
Pageof 50